IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

May 2014 (Vol: 2014, Issue: 5)

Next Issue >>

Download pdf of entire issue

Section: Licensing
Celgene Pays US$710 M Upfront to License Nogra Pharma’s Phase III-Ready GED-0301 Published: 20 May-2014
By: Heather Cartwright
Abstract Fulltext:
Roche Partners with Oryzon Genomics and Spero Therapeutics Published: 21 May-2014
By: Heather Cartwright
Abstract Fulltext:
Section: Mergers & Acquisitions
Baxter Strengthens Haemophilia Franchise with Chatham Therapeutics Purchase as Biogen Enters Market Published: 2 May-2014
By: Heather Cartwright
Abstract Fulltext:
Sun Pharma Agrees to Buy Struggling Ranbaxy from Daiichi Sankyo in US$4 B Deal Published: 9 May-2014
By: Heather Cartwright
Abstract Fulltext:
Mallinckrodt Expands Speciality Pharmaceuticals Business with US$5.6 B Questcor Acquisition Published: 10 May-2014
By: Heather Cartwright
Abstract Fulltext:
Novartis and GSK Shift M&A Paradigm with Trio of Deals Published: 14 May-2014
By: Heather Cartwright
Abstract Fulltext:
BioAlliance Pharma and Topotarget Agree to Merge and Combine Late-State Orphan Oncology Assets Published: 16 May-2014
By: Heather Cartwright
Abstract Fulltext:
Forest Expands Gastrointestinal Portfolio with up to US$1.46 B Furiex Purchase Published: 23 May-2014
By: Heather Cartwright
Abstract Fulltext:
BMS Buys iPierian and its Anti-Tau Programme for a Potential US$725 M Published: 28 May-2014
By: Heather Cartwright
Abstract Fulltext:
Bayer Wins Auction for Merck & Co.’s OTC Business and Offers Cardiovascular Disease Collaboration Sweetener Published: 30 May-2014
By: Heather Cartwright
Abstract Fulltext:

Login

Username:

Password:

Keep me logged in